Lincoln Pharmaceuticals Ltd

Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity shares of face value 10/- each for the Financial year Ended 31st March 2025 subject to approval of the members at the ensuing A.G.M of the Company.